Status:
RECRUITING
Human Upper Extremity Allotransplantation: F/U Protocol
Lead Sponsor:
Johns Hopkins University
Conditions:
Amputation, Traumatic
Wounds and Injury
Eligibility:
All Genders
18-100 years
Brief Summary
Upper extremity allotransplantation is a new procedure which is becoming more common in the United States. Ongoing data collection for research purposes is vital to the long-term assessment as to the ...
Eligibility Criteria
Inclusion
- Males and females 5 or more years post-unilateral or bilateral upper limb transplantation.
- Completes the protocol informed consent form.
- Consents to sample collection and storage (biopsies).
- USA citizen or equivalent.
- Patient agrees to comply with the protocol and states a dedication to the immunomodulatory treatment regime.
Exclusion
- Candidate has not received an upper extremity allotransplant.
- Any reason the study team thinks would cause the participant to be noncompliant or would put the patient at unacceptable risk if enrolled.
Key Trial Info
Start Date :
July 25 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2036
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03400345
Start Date
July 25 2017
End Date
July 30 2036
Last Update
May 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States, 21287